Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 13/20 | 0.54 |
| ▸ | CA2 | P00918 | 13/20 | 0.54 |
| ▸ | CA12 | O43570 | 12/20 | 0.54 |
| ▸ | CA9 | Q16790 | 12/20 | 0.54 |
| ▸ | CA4 | P22748 | 7/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20607758 | 0.83 | CA1 (0.60) | CA1CA2CA12CA9CA4 | |
| SCHEMBL30278264 | 0.83 | CA1 (0.60) | CA1CA2CA12CA9 | |
| SCHEMBL23004815 | 0.83 | CA1 (0.60) | CA1CA2CA12CA9 | |
| SCHEMBL1233210 | 0.82 | CA12 (0.57) | CA1CA2CA12CA9CA4 | |
| SCHEMBL2299412 | 0.81 | CA12 (0.60) | CA1CA2CA12CA9CA4 | |
| SCHEMBL1233465 | 0.80 | CA12 (0.55) | CA1CA2CA12CA9CA4 | |
| SCHEMBL14986243 | 0.79 | CA1 (0.53) | CA1CA2CA12CA9CA4 | |
| SCHEMBL10268864 | 0.78 | CA1 (0.66) | CA1CA2CA12CA9CA4 | |
| SCHEMBL30616853 | 0.77 | CA1 (0.59) | CA1CA2CA12CA9CA4 | |
| SCHEMBL23005073 | 0.76 | CA1 (0.59) | CA1CA2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3423065-B1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS INC (US) | 2021-07-21 | — | — | EP | claimed |
| EP-3423065-B1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS INC (US) | 2021-07-21 | — | — | EP | disclosed |
| US-10919916-B2 | Boron-containing small molecules | BILL & MELINDA GATES FOUNDATION (US) | 2021-02-16 | — | — | US | disclosed |
| US-20200247827-A1 | BORON-CONTAINING SMALL MOLECULES | BILL & MELINDA GATES FOUNDATION (US) | 2020-08-06 | — | — | US | disclosed |
| US-10611780-B2 | Boron-containing small molecules | BILL AND MELINDA GATES FOUNDATION (US) | 2020-04-07 | — | — | US | disclosed |
| US-20190077814-A1 | BORON-CONTAINING SMALL MOLECULES | GATES FOUNDATION | 2019-03-14 | — | — | US | disclosed |
| EP-3423065-A1 | BORON-CONTAINING SMALL MOLECULES | Anacor Pharmaceuticals, Inc. (US) | 2019-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190077814-A1 | BORON-CONTAINING SMALL MOLECULES | BCL6B, BLVRB, BTD | CA1 3591/4885CA2 743/4885CA12 603/4885 |
| US-10919916-B2 | Boron-containing small molecules | BCL6B, BLVRB, BTD | CA1 3591/4885CA2 743/4885CA12 603/4885 |
| US-10611780-B2 | Boron-containing small molecules | BCL6B, BLVRB, BTD | CA1 3591/4885CA2 743/4885CA12 603/4885 |
| US-20200247827-A1 | BORON-CONTAINING SMALL MOLECULES | BCL6B, BLVRB, BTD | CA1 3591/4885CA2 743/4885CA12 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.